摘要将101例不稳定型心绞痛合并糖尿病患者随机分为治疗组和对照组,在常规服用传统药物的基础上,治疗组加服曲美他嗪20 m g,3次/d,共8周。治疗后治疗组每周心绞痛发作次数、硝酸甘油消耗量较治疗前明显减少。可见在常规治疗基础上联用曲美他嗪,可以使不稳定型心绞痛合并糖尿病患者的心绞痛症状减轻,运动耐量增加,且安全性好。
2Stanley WC.Metabolic therapy in the treatment of ischaemic heart disease:the pharmacology of trimetazidine[J].Fundam Clin Pharmacol,2003,17(2):133-145.
二级参考文献4
1C. Monpère,M. Brochier,J. Demange,G. Ducloux,J.F. Warin. Combination of trimetazidine with nifedipine in effort angina[J] 1990,Cardiovascular Drugs and Therapy(4):824～825
2Sergio Dalla-Volta,Giuseppe Maraglino,Patricia Della-Valentina,Pietro Viena,Alessandro Desideri. Comparison of trimetazidine with nifedipine in effort angina: A double-blind, crossover study[J] 1990,Cardiovascular Drugs and Therapy(4):853～859
3J. F. Renaud MD. Internal pH, Na+, and Ca2+ regulation by trimetazidine during cardiac cell acidosis[J] 1988,Cardiovascular Drugs and Therapy(6):677～686
4P. Sellier,P. Audouin,B. Payen,P. Corona,T. C. Duong,P. Ourbak. Acute effects of trimetazidine evaluated by exercise testing[J] 1987,European Journal of Clinical Pharmacology(2):205～207
